• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2200245 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products Supplementary Application 2022-10-12 Shanghai RAAS Blood Products Co Ltd view
CXSS2300087 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2023-11-10 Lanzhou Lansheng Plasma-derived Biotheraples Co Ltd view
CXSS2200022 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2022-03-08 Guangdong Shuanglin Bio-Pharmacy Co Ltd view
CYSB2200141 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products Supplementary Application 2022-06-08 Shanghai RAAS Blood Products Co Ltd view
CYSB2400055 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(原15) Supplementary Application 2024-03-01 China Resources Boya Bio-pharmaceutical Group Co Ltd view
CXSL2300641 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2023-09-22 China National Pharmaceutical Group Guizhou Biopharmaceutical Co Ltd view
CYSB2101132 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products Supplementary Application 2021-07-29 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CXSS2200091 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2022-11-18 Shenzhen Weiguang Biological Products Co Ltd view
CYSB2400045 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) Supplementary Application 2024-02-24 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2200164 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(原15) Supplementary Application 2022-06-28 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CXSS2101050 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2021-11-12 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2400258 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products Supplementary Application 2024-09-26 Sinopharm Kunming Blood Products Co Ltd view
CYSB2101031 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(原15) Supplementary Application 2021-04-12 Shanxi Kangbao Biological Product Co Ltd view
CYSB2200163 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(原15) Supplementary Application 2022-06-28 Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd view
CYSB2400046 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) Supplementary Application 2024-02-24 Hualan Biological Engineering Chongqing Co Ltd view
CXSS2200050 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2022-05-10 Lanzhou Lansheng Plasma-derived Biotheraples Co Ltd view
CXSL2400371 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2024-06-07 Sichuan Yuanda Shuyang Pharmaceutical Co Ltd view
CXSS2101051 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2021-11-12 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2200140 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products Supplementary Application 2022-06-08 Shanghai RAAS Blood Products Co Ltd view
CXSL2400019 人凝血酶原复合物 human prothrombin complex Lyophilized Biological Products(3.4) New Drug Application 2024-01-10 Wuhan Biopharmaceutical Co Ltd of China National Pharmaceutical Group view